Lacrifill for Ocular Surface Optimization in Cataract Surgery
Evaluation of Lacrifill™ Canalicular Filler for Optimization of Ocular Surface Parameters and Biometric Precision in Prospective Cataract Surgery Patients With Dry Eye Disease
1 other identifier
observational
65
1 country
1
Brief Summary
This is a single-site observational study designed to evaluate the efficacy of Lacrifill™ canalicular filler in optimizing ocular surface parameters and biometric precision in prospective cataract surgery patients with dry eye disease (DED).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2026
CompletedFirst Posted
Study publicly available on registry
June 15, 2026
CompletedStudy Start
First participant enrolled
July 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2027
Study Completion
Last participant's last visit for all outcomes
July 15, 2027
June 15, 2026
June 1, 2026
1 year
June 9, 2026
June 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Mean absolute error (MAE)
Difference in mean spherical equivalent Mean Absolute Error (MAE) between actual postoperative manifest refraction spherical equivalent and back-calculated equivalent based on baseline biometry.
1 month postoperatively
Secondary Outcomes (4)
Difference in mean magnitude of postoperative refractive astigmatism
1 month postoperatively
Lens type candidacy
Preoperative assessment
Postoperative uncorrected visual acuity (logMAR)
1 month postoperatively
Subjective visual satisfaction
1 month postoperatively
Study Arms (1)
Lacrifill Canalicular Filler
Observational Study
Interventions
Eligibility Criteria
Subjects aged 40 years or older with diagnosed dry eye disease, totaling 65 eyes enrolled.
You may qualify if:
- Age \>= 40 years
- Diagnosed dry eye (OSDI \>= 13, TBUT \< 10 sec, or Oxford staining \>= Grade 2)
- No recent ocular surgeries (\<6 months)
- No significant changes in DED regimen within last 1 month
You may not qualify if:
- Previous punctal plugs or canalicular cautery
- Active ocular inflammation or corneal pathology unrelated to DED
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Eye Institute of West Floridalead
- Sengicollaborator
Study Sites (1)
The Eye Institute of West Florida
Largo, Florida, 33770, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neel Desai, MD
The Eye Institute of West Florida
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2026
First Posted
June 15, 2026
Study Start (Estimated)
July 15, 2026
Primary Completion (Estimated)
July 15, 2027
Study Completion (Estimated)
July 15, 2027
Last Updated
June 15, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share